Combination brings long-term remission in acute promyelocytic leukemia refractory for both all-trans retinoic acid and arsenic trioxide

European Journal of Haematology

Volumn 81, Issue 2, 2008, Pages 160-

  Sasaki, Makoto ^a   Sugimoto, Koichi ^a   Isobe, Yasushi ^a   Oshimi, Kazuo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; CYTARABINE; IDARUBICIN; RETINOIC ACID;

ADULT; BONE MARROW EXAMINATION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; FEMALE; FOLLOW UP; HUMAN; JAPANESE; LETTER; LEUKOCYTE COUNT; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; QT PROLONGATION; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARSENICALS; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MIDDLE AGED; OXIDES; REMISSION INDUCTION; SALVAGE THERAPY; TRETINOIN;

EID: 47649130870     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01079.x     Document Type: Letter

References (4)

1. Shen ZX, Shi ZZ, Fang J, et al. All-trans retinoic acid/AS2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad USA 2004 101 : 5328 35.
2. Wang G, Li W, Cui J, et al. An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose all-trans retinoic acid. Hematol Oncol 2004 22 : 63 71.
3. Estey E, Garcia-Manero G, Ferrajoli A, Federl S, Verstovsek S, Jones D, Kantanjian H. Use of all-trans retinoic acid plus arsenic tioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia. Blood 2006 107 : 3469 73.
4. Au WY, Chim CS, Lie AK, Liang R, Kwong YL. Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukemia recurring from previous relapses successfully treated using arsenic trioxide. Br J Haematol 2002 117 : 130 2.